News Related to Pentagon

Related coverage linked through entity extraction aliases.

US Expands National Security Scrutiny of Biotechnology Sector

Aug 07, 2026

Biotechnology is now a national security issue in Washington, with investment restrictions, export controls, and procurement bans targeting China. The Pentagon designated WuXi AppTec as a Chinese military company, sparking a legal challenge. Policymakers also warn about supply chain dependence, biosecurity, and the dual-use dilemma.

Novartis CEO Vas Narasimhan joins Anthropic board

Apr 16, 2026

Novartis chief executive Vas Narasimhan has joined Anthropic’s board. The appointment adds a pharma executive as Anthropic expands into drug discovery and launches Claude for Life Sciences.